RJA
ESRX

Raymond James & Associates’s Express Scripts Holding Company ESRX Stock Holding History

Raymond James & Associates’s Portfolio ESRX Stock Details ESRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-11,100
Closed -$37K – 3791
2018
Q3 		$37K Buy
+11,100
New +$946K ﹤0.01% 3511
2018
Q1 		– Sell
-23,900
Closed -$129K – 3643
2017
Q4 		$129K Sell
23,900
-2,600
-10% -$166K ﹤0.01% 3170
2017
Q3 		$21K Buy
26,500
+4,700
+22% +$292K ﹤0.01% 3314
2017
Q2 		$24K Buy
21,800
+4,600
+27% +$289K ﹤0.01% 3245
2017
Q1 		$1K Buy
17,200
+6,900
+67% +$475K ﹤0.01% 3288
2016
Q4 		$1K Sell
10,300
-1,600
-13% -$115K ﹤0.01% 3236
2016
Q3 		$1K Buy
11,900
+1,200
+11% +$89.7K ﹤0.01% 3211
2016
Q2 		$3K Buy
+10,700
New +$787K ﹤0.01% 3001

Other funds holding ESRX

SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $5.38B AUM 27.31% 1-Year Est. Return
BSPF
British Steel Pension Fund London, United Kingdom $410M AUM 11.96% 1-Year Est. Return
MYAM
Meiji Yasuda Asset Management Tokyo, Japan $2B AUM 22.52% 1-Year Est. Return
AWM
Alterna Wealth Management Houston, Texas $174M AUM 15.45% 1-Year Est. Return
W
Wealthquest Cincinnati, Ohio $1.59B AUM 18.1% 1-Year Est. Return
ACA
Atlas Capital Advisors Jackson, Wyoming $875M AUM
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
SBL
Sargent Bickham Lagudis Boulder, Colorado $1.22B AUM 14.94% 1-Year Est. Return

Raymond James & Associates's ESRX Position: Q4 2018 in Review

Raymond James & Associates sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 427,462 shares — an estimated $40.6M sold.

Raymond James & Associates first reported a position in ESRX in Q2 2013 and held it in 22 quarters. The position peaked at $57.3M in Q4 2015. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Raymond James & Associates reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Raymond James & Associates sold 427,462 Express Scripts Holding Company shares in Q4 2018, an estimated $40.6M.
  • Raymond James & Associates first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 22 quarters.
  • Raymond James & Associates's Express Scripts Holding Company position peaked at $57.3M in Q4 2015.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.